Company / R&D Expense
Healthcare Triangle, Inc. R&D Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$429.0K
FY2025
5-year range
$429.0K / $6.0M
FY2021-FY2025
Trend
-46.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $6M to $429,000 over the past 2 years.
Based on SEC 10-K filings.
$429,000 in FY2025 with a 3-year CAGR of -56.6%.
Declined from $6M to $429,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -56.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -56.6%, indicating a declining trend.
- In FY2025, r&d expense decreased 46.3% year-over-year.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.81 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $429.0K | -46.3% |
| FY2024 | $799.0K | -86.6% |
| FY2023 | $6.0M | +13.3% |
| FY2022 | $5.3M | +201.6% |
| FY2021 | $1.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026